Income Statement Balance Sheet Cash Flow Segments

Enbridge Cash Flow Statement

Operating, investing, and financing cash movements

Enbridge generated $11.6B in operating cash flow over the trailing twelve months. After $9.7B in capital expenditures, free cash flow was $1.9B. Free cash flow decreased 0.6% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)11559000000.00 Net Cash From Investing (TTM)-11539000000.00 Net Cash From Financing (TTM)-339000000.00 Capital Expenditures (TTM)9689000000.00 Depreciation And Amortization Cf (TTM)5686000000.00 Net Change In Cash (TTM)-352000000.00

Latest FilingQ1 2026

Report Date2026-05-08

Market Cap$123.09B

P/E Ratio17.83

ROE10.37%

Investing

Metric	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Acquisitions, net of cash acquired	407000000.00	0.00	0.00	0.00	0.00	—
Capital expenditures	2546000000.00	1723000000.00	1900000000.00	2321000000.00	3029000000.00	2439000000.00
Payment for (Proceeds from) Other Investing Activity	—	16000000.00	—	—	—	20000000.00
Payments to Acquire Intangible Assets	—	60000000.00	—	—	—	76000000.00
Payments to Acquire Long-Term Investments	—	304000000.00	—	—	—	503000000.00
Sales of and distributions from equity method investments	—	130000000.00	—	—	—	0.00
Net cash from investing activities	-4448000000.00	-1789000000.00	-2859000000.00	-2539000000.00	-3316000000.00	-2825000000.00
Dividend Received from Consumer Healthcare JV	—	184000000.00	—	—	—	213000000.00

Financing

Metric	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Proceeds from minority shareholders	—	5000000.00	—	—	—	6000000.00
Repayments of debt	1018000000.00	2742000000.00	1337000000.00	2035000000.00	735000000.00	67000000.00
Distributions to noncontrolling interests	87000000.00	100000000.00	95000000.00	81000000.00	84000000.00	82000000.00
Dividends paid	1990000000.00	2054000000.00	2055000000.00	2055000000.00	2056000000.00	2116000000.00
Distributions To Redeemable Noncontrolling Interest	0.00	0.00	—	—	—	17000000.00
Payments of Ordinary Dividends, Preferred Stock and Preference Stock	—	102000000.00	—	—	—	107000000.00
Proceeds From Investment By Redeemable Noncontrolling Interest In Subsidiary Net Of Transaction Costs	0.00	178000000.00	178000000.00	178000000.00	178000000.00	—
Proceeds From Issuance Of Long Term Debt Net Of Issuance Costs	932000000.00	2777000000.00	3753000000.00	1784000000.00	2642000000.00	4746000000.00
Other, net	—	-36000000.00	—	—	—	-54000000.00
Proceeds From Redeemable Noncontrolling Interest	0.00	0.00	—	—	—	6000000.00
Proceeds From Repayments Of Commercial Paper And Lines Of Credit	3273000000.00	967000000.00	-1464000000.00	1285000000.00	508000000.00	-1692000000.00
Proceeds from (Repayments of) Short-Term Debt	—	330000000.00	—	—	—	458000000.00
Proceeds from related party debt	0.00	0.00	25000000.00	14000000.00	2000000.00	30000000.00
Net cash from financing activities	601000000.00	-950000000.00	-1216000000.00	-126000000.00	-108000000.00	1111000000.00
Proceeds from issuance of common stock	0.00	5000000.00	1000000.00	2000000.00	20000000.00	0.00

Operating

Metric	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Deferred income taxes	0.00	304000000.00	487000000.00	153000000.00	81000000.00	271000000.00
Depreciation and amortization	1384000000.00	1408000000.00	1391000000.00	1398000000.00	1464000000.00	1433000000.00
Realized Gain (Loss) on Disposal of Equity Method Investment	—	—	0.00	0.00	—	—
Net cash from operating activities	3662000000.00	3053000000.00	3238000000.00	2868000000.00	3111000000.00	2342000000.00
Net income	618000000.00	2490000000.00	2321000000.00	847000000.00	2131000000.00	1778000000.00
Adjustment For Income Loss Of Equity Method Investments	-640000000.00	-729000000.00	-510000000.00	-451000000.00	-534000000.00	-541000000.00
Distributions of earnings from equity method investees	—	557000000.00	—	—	—	462000000.00
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital	—	899000000.00	—	—	—	1921000000.00
Other Noncash Income (Expense)	—	-14000000.00	—	—	—	33000000.00
Gain (loss) on mark-to-market of Escrowed Shares	—	92000000.00	—	—	—	-893000000.00

Free Cash Flow

Metric	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Free cash flow	$1.1B	$1.3B	$1.3B	$547.0M	$82.0M	-$97.0M

Other

Metric	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Effect of exchange rate changes on cash	83000000.00	8000000.00	-63000000.00	27000000.00	-19000000.00	22000000.00
Net increase (decrease) in cash	-102000000.00	322000000.00	-900000000.00	230000000.00	-332000000.00	650000000.00

Supplemental

Metric	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Interest paid	1033500000.00	1231000000.00	1231000000.00	1231000000.00	1231000000.00	—